– Signed an MOU with Molbio Diagnostics to manufacture infectious disease testing machines, including COVID-19 PCR Analyzers. – Q1 FY24 financial results: Reported a consolidated total income of Rs 3,274.35 crore (up 14.67% YoY) with a net profit of Rs 64.16 crore. – Stock price as of October 3, 2023, closed at Rs 5,289.25 (0.38% increase from the previous day).